Moolec Science SA (NASDAQ:MLEC) shares are down on Wednesday. On Tuesday, the company announced a significant breakthrough in molecular farming.
Moolec said it successfully demonstrated the stable expression of bovine myoglobin in pea seeds, expanding its molecular farming platform, which could enhance its market position in the alternative protein sector.
Moolec Science has achieved a milestone by producing bovine myoglobin in pea seeds through a 28-month research project with a leading U.S. academic institution.
This breakthrough reinforces the company’s ability to expand its molecular farming capabilities and could unlock new pathways for scalable protein production.
Technical Analysis
At $10.80, the stock is trading 28.1% above its 20-day simple moving average (SMA) and 21.8% above its 50-day SMA, suggesting a bullish short-term trend. However, it is trading 49.7% below its 200-day SMA, indicating a bearish long-term trend that traders should monitor closely.
The relative strength index (RSI) is currently at 58.88, suggesting that the stock is in neutral territory, …
This post was originally published here
